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Abstract
 
Leukocyte infiltration into inflammatory sites is regulated by the expression of adhesion and
activation proteins, yet the role of these proteins in shear-dependent transmigration is poorly
understood. We examined eosinophil recruitment on cytokine-stimulated human umbilical
vein endothelial cells (HUVECs) under laminar flow conditions. Eosinophils rapidly transmi-
grated on interleukin (IL)-4–, but not TNF-stimulated HUVECs. Transmigration was shear
dependent, with up to 90% of eosinophils transmigrating in the presence of shear and less than
25% of cells transmigrating under static conditions. Eosinophils express CC chemokine recep-
tor CCR3 and are responsive to various CC chemokines. The effects of chemokines are me-
 
diated primarily through G
 
 
 
i
 
, which is pertussis toxin sensitive. Greater than 65% of shear-
dependent eosinophil transmigration on IL-4–stimulated HUVECs was blocked by either
pertussis toxin or by an anti-CCR3 monoclonal antibody. Using reverse transcription poly-
 
merase chain reaction (RT-PCR) and Western blots, we found that IL-4–stimulated HUVECs
produce both mRNA and protein for eotaxin-3. Eotaxin-3 was both released by HUVECs and
expressed on the endothelial cell surface. Pretreatment of HUVECs with an anti–eotaxin-3 an-
tibody blocked eosinophil transmigration to the same extent as an anti-CCR3 antibody. These
results indicate that IL-4–stimulated HUVECs support shear-dependent eosinophil transmi-
gration by upregulating eotaxin-3, and that surface association is critical for the role of eo-
taxin-3 in transmigration.
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Introduction
 
Inappropriate leukocyte recruitment is a hallmark of in-
flammatory diseases such as rheumatoid arthritis, inflamma-
tory bowel disease and bronchial asthma. Selective recruit-
ment of eosinophils and lymphocytes into the lung is
thought to contribute to many of the features of asthma in-
cluding increased cytokine production, epithelial cell shed-
ding, mucous hyper-secretion, and airway hyper-respon-
siveness (1–3). The cytokines TNF, IL-1
 
 
 
, IL-4, and IL-13
have all been used to stimulate human umbilical vein endo-
thelial cells (HUVECs)
 
*
 
 and these endothelial cells can sup-
port binding of several classes of leukocytes, including eo-
sinophils (4–8). We have focused on IL-4 as a model for
eosinophil recruitment, as this cytokine has been shown to
participate in selective eosinophil recruitment both in vitro
and in vivo. In vivo, IL-4 regulates several immune re-
sponses including IgE synthesis by B cells, promotion of
the Th2 phenotype in T cells, and increased infiltration of
eosinophils to inflammatory sites (9, 10). Recently we
showed that IL-4–stimulated HUVECs support the selec-
tive recruitment of eosinophils from whole blood under
flow conditions in vitro (11).
The generic cascade of events that leads to the move-
ment of leukocytes from the bloodstream into the tissue in-
cludes tethering and rolling of leukocytes followed by acti-
vation and transmigration (12, 13). The first half of this
cascade is well characterized, especially in regards to the
roles of the selectins and vascular cell adhesion molecule-1
(VCAM-1) in the initial tethering and rolling of leukocytes
along the inflamed endothelium (12, 13). In contrast, the
 
✪
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subsequent events regulating activation and transmigration
are less clear but are thought to involve activation by che-
motactic factors and the use of adhesion molecules such as
 
 
 
4- and 
 
 
 
2-integrins and platelet-endothelial cell adhesion
molecule-1 (PECAM-1). Together these proteins facilitate
firm adhesion and subsequent transmigration through en-
dothelial cell junctions (12, 14, 15). Although these inter-
actions occur under the shear conditions found in the vas-
culature, in vitro laminar flow chamber systems have only
recently been used to examine activation and transmigra-
tion of leukocytes (5, 16, 17).
Eosinophil transmigration across cytokine-activated en-
dothelial cells has only been examined in static systems.
These studies are limited by the fact that freshly isolated,
normal eosinophils do not transmigrate across either IL-1–
or IL-4–stimulated HUVECs (18–20). As a result, most
eosinophil transmigration studies have focused on eosino-
phil migration across coated filters or unactivated HU-
VECs in response to chemoattractants such as chemokines.
Chemokines are a family of small chemotactic proteins
that are subdivided into two main groups, CC and CXC,
based on the spacing of the first two conserved cysteine
residues (14, 21, 22). Eosinophils express CC chemokine
receptors CCR1 and CCR3 and respond to many chemo-
kines including RANTES (regulated upon activation, nor-
mal T cell expressed and secreted), monocyte chemoat-
tractant protein (MCP)-3, MCP-4, and the eotaxins (23,
24). Only the eotaxin family members (eotaxin, eotaxin-2,
and eotaxin-3) act exclusively at CCR3 (23); however,
these proteins have distinct patterns of expression. For ex-
ample, mRNA for eotaxin-3, but not eotaxin, is specifi-
cally increased in IL-4– and IL-13–stimulated HUVECs
but not in TNF- or IL-1–stimulated HUVECs (25). Thus
these proteins will likely have distinct roles in eosinophil
recruitment.
In this study we examined eosinophil transmigration on
cytokine-stimulated endothelial cells using an in vitro lami-
nar flow chamber to simulate the hydrodynamic shear con-
ditions found in vivo. Eosinophils transmigrated on IL-4–
stimulated HUVECs, but not on TNF-stimulated cells.
Eosinophil transmigration on IL-4-stimulated HUVECs
was rapid, with 50% of eosinophils transmigrating within 7
min. This rapid transmigration was absolutely dependent
on shear conditions, as less than 15% of eosinophils trans-
migrated in the same time frame under static conditions.
Even after 20 min, less than 25% of eosinophils transmi-
grated under static conditions, whereas transmigration un-
der shear conditions climbed as high as 90%. Eosinophil ac-
tivation was, in part, pertussis toxin sensitive and required
CCR3. Using antibodies directed against eotaxin-3, we
found that IL-4–stimulated HUVECs synthesized eotaxin-3
and both released the protein and expressed it on the cell
surface. Furthermore, surface-associated eotaxin-3 was re-
sponsible for the CCR3-dependent component of eosino-
phil transmigration. This is the first time that a functional
role for eotaxin-3 has been demonstrated. These results in-
dicate that shear-dependent eosinophil transmigration is
regulated by the expression of eotaxin-3. These data are
 
profoundly different from those obtained using static sys-
tems, suggesting that studying leukocyte transmigration un-
der the flow conditions that exist in the vasculature may
provide more accurate insight into the molecular mecha-
nisms that govern this process.
 
Materials and Methods
 
Reagents.
 
Hanks’ balanced salt solution with Ca
 
2
 
 
 
 and Mg
 
2
 
 
 
(HBSS), lymphoprep 1077, Media 199 (M199), Superscript II,
TRIzol reagent, and tetramethylbenzidine (TMB) one-step
ELISA substrate were from Invitrogen. PCR Master Mix was
from QIAGEN. Human serum albumin (HSA) was from Im-
muno US. Enhanced chemiluminescence reagents were from
Pierce Chemical Co. Pertussis toxin and histamine were from
Sigma-Aldrich. MEK1 inhibitor PD 98059 was from Calbio-
chem-Novabiochem. Oligonucleotide probes were prepared by
the DNA synthesis lab at the University of Calgary. All plas-
ticware was from Becton Dickinson. All other chemicals were
from BDH, Inc.
 
Proteins and Antibodies.
 
Human recombinant IL-4, human re-
combinant TNF, anti-CCR3 mAb, anti-MCP-4 mAb, and
ELISA kits for eotaxin and RANTES were from R&D Systems.
Anti-eotaxin and anti-RANTES mAbs were purchased from Se-
rotec. Anti-eotaxin-3 antibodies were from PeproTech. Goat-
anti–human isotype control antibody and donkey anti–goat
horseradish peroxidase (HRP)-conjugated antibody were from
Santa Cruz Biotechnology, Inc. Anti-CD16 and anti-CD3 mag-
netic beads were from Miltenyi Biotec. All antibodies were used
according to manufacturers’ instructions or as described.
 
Cell Isolation.
 
Blood from healthy and mildly atopic adults
was drawn into heparinised syringes and granulocytes were iso-
lated by dextran sedimentation, hypotonic lysis, and density cen-
trifugation on lymphoprep 1077. Eosinophils were then nega-
tively selected by depleting neutrophils and any remaining
lymphocytes using magnetic cell separation with anti-CD16 and
anti-CD3 paramagnetic beads. The resulting eosinophils were
routinely 
 
 
 
95% pure by Kimura staining. Primary or first passage
HUVECs were isolated as described (26) and maintained in
M199 with 20% human serum. For all experiments, HUVECs
were used 2 d postconfluence. The Ethics Committee at the Uni-
versity of Calgary approved all procedures.
 
Adhesion and Transmigration Under Flow Conditions.
 
Eosino-
phil interactions under flow conditions were quantified as de-
scribed (7). Briefly, confluent monolayers of endothelial cells
were washed and stimulated with either M199 with 0.5% HSA
(M199/A) alone or M199/A containing either 20 ng/ml IL-4 or
20 ng/ml TNF. After 6 or 24 h, the incubation buffer was re-
moved, the flow cell was assembled and freshly isolated eosino-
phils (5 
 
 
 
 10
 
5
 
/ml) were perfused across endothelial monolayers.
Accumulation was determined after 4 min at 2 dyn/cm
 
2
 
 in all
experiments. After 4 min of perfusion, the inlet line was trans-
ferred to HBSS to prevent the binding of new eosinophils and
shear was maintained at 2 dyn/cm
 
2
 
. Transmigration was then as-
sessed between 6 and 7 min unless otherwise specified. Interact-
ing cells were visualized using 400
 
 
 
 magnification and recorded
via a CCD camera for later analysis. We characterized transmi-
grated cells in a manner similar to previous studies (5, 16). Roll-
ing and adherent cells on the surface of the endothelium appear
phase-bright, whereas transmigrated cells are flattened and phase-
dark (Fig. 1). Flattened, phase-dark cells were confirmed as being
under the endothelial cell monolayer by observing the focal 
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plane of the eosinophils and the endothelial cells using 800
 
 
 
magnification. A cell was considered transmigrated if greater than
50% of the cell was under the monolayer at the point of quantifi-
cation. Following cells for longer periods of time demonstrated
that those cells that had become greater than 50% transmigrated
continued to migrate and remain under the monolayer under
shear conditions. Transmigration is expressed as the number of
transmigrated cells divided by the total cells counted. In most ex-
periments, 5–10 fields of view were used, and 100–150 cells
were counted.
In some experiments eosinophils or HUVECs were treated
with saturating concentrations of the specified antibodies for 10
min before assembly of the flow chamber. In other experiments,
HUVECs were pretreated with 20 
 
 
 
M PD 98059 or an equiva-
lent amount of DMSO for 30 min or with 10 
 
 
 
M histamine for
10 min before assemble of the flow chamber. Finally, eosinophils
(5 
 
 
 
 10
 
6
 
/ml) were pretreated with 250 ng/ml pertussis toxin for
1 h at 37
 
 
 
C. A dose response curve was performed to ensure that
the pertussis toxin was used at saturation. The cells were washed
twice with HBSS, resuspended at 5 
 
 
 
 10
 
5
 
 cells/ml, and used in
transmigration experiments.
 
Transmigration Under Static Conditions.
 
Eosinophils (5 
 
 
 
 10
 
5
 
/
ml) were drawn into the flow chamber, the flow was stopped,
and the cells were observed for up to 20 min. Percent transmi-
gration was assessed at the specified times using video microscopy
as described in the previous section. Unlike transmigration under
shear conditions, cells that had partially transmigrated frequently
retracted their processes (see online supplemental material). This
resulted in an overestimate of transmigrated cells under static
conditions.
 
Reverse Transcription PCR.
 
Endothelial cells were stimulated
with buffer alone or buffer containing 20 ng/ml IL-4 for 24 h as
described above. Reverse transcription (RT)-PCR was per-
formed to detect mRNA for RANTES, eotaxin, eotaxin-2, eo-
taxin-3, MCP-3, MCP-4, and 
 
 
 
-actin. RNA was isolated using
TRIzol according to manufacturer’s instructions. Reverse tran-
scription was performed using First strand synthesis kit from
GIBCO BRL according to manufacturer’s instructions. PCR was
performed with QIAGEN Master Mix using 2 
 
 
 
l of the RT re-
action as template cDNA and the appropriate primer pairs. Prim-
ers pairs were designed based on published sequences. After 35
cycles, amplified PCR products were identified by electrophore-
sis as described previously (27).
 
ELISA for CCR3-active Chemokines.
 
Endothelial cells were
stimulated with buffer alone or buffer containing 20 ng/ml IL-4
for 24 h as described above. The supernatants from these cells
were collected and ELISAs were performed to detect the pres-
ence of eotaxin, RANTES, or MCP-3 according to manufac-
turer’s instructions. ELISA kits are not available for eotaxin-3;
therefore we developed a sandwich ELISA for eotaxin-3. Immu-
nosorp plates from NUNC were coated overnight with anti-
eotaxin-3 antibody (0.5 
 
 
 
g/ml) in carbonate coating buffer (0.1 M
Na carbonate, pH 9.2). The plates were washed four times with
HBSS and supernatants or eotaxin-3 standard diluted in M199/A
were added to the plate. After 2 h at 37
 
 
 
C, the supernatants were
discarded and the plates were washed four times before the addi-
tion of biotinylated anti-eotaxin-3 antibody (0.25 
 
 
 
g/ml in
HBSS/A). After an additional 2 h, the plates were washed four
times and streptavidin-conjugated HRP at a 1:1,000 dilution in
HBSS/A was added to the wells. Plates were again incubated for
2 h and washed four times before the addition of TMB one-step
ELISA substrate. After 15 min the reaction was stopped by the
addition of 1 M H
 
3
 
PO
 
4
 
 and the plates were read at 450 nm.
 
Western Blotting and Cell Surface ELISA for Eotaxin-3.
 
Endo-
thelial cells were stimulated with buffer alone or buffer containing
20 ng/ml IL-4 for 24 h as described above. Total protein expres-
sion in control and IL-4–stimulated HUVECs was determined by
Western blotting using an eotaxin-3 antibody to probe the mem-
branes. Recombinant eotaxin-3 and recombinant MCP-4 were
used as positive and negative controls, respectively. Surface ex-
pression of eotaxin-3 on control and IL-4–stimulated endothelial
cells was determined using a modified ELISA as described (27).
Briefly, stimulated cells were washed once with ice cold HBSS
and 2 
 
 
 
g/ml anti-eotaxin-3 or an isotype matched nonimmune
antibody in HBSS/A was added and incubated for 60 min on ice.
Cells were washed three times with HBSS and then incubated
with a 1:1,000 dilution of HRP-conjugated donkey anti–goat
IgG secondary antibody for 60 min on ice. Antibody binding was
determined using TMB one-step ELISA substrate and quantified
by measuring absorbance at 450 nm.
 
Statistics.
 
All experiments were performed at least three
times. The data were analyzed using either unpaired Student’s 
 
t
 
test or by using analysis of variance (ANOVA) followed by the
Bonferroni test for intergroup comparisons. 
 
P
 
 values 
 
 
 
 0.05 were
considered significant.
 
Online Supplemental Material.
 
Time-lapse images of eosino-
phils interacting with IL-4–stimulated HUVEC are shown in on-
line supplemental Videos 1–3. All videos were captured for 4–5
min at 30 frames per second and compressed to 15–20 s using
Adobe Premiere. Thus, the videos are presented at 15
 
 
 
 time
compression. Images were captured using a 40
 
 
 
 objective on a
ZEISS Axiovert 100 microscope coupled to a CCD camera as
described in the previous section. Video 1 shows eosinophils in-
teracting with IL-4–stimulated HUVECs under static conditions.
Eosinophils move across the endothelial cell surface and remain
phase bright, but do not migrate beneath the monolayer. Video 2
also shows eosinophils interacting under static conditions with
IL-4–stimulated HUVECs. Here eosinophils attempt to transmi-
grate but are unable to do so and retract their pseudopods. Video
3 shows eosinophils interacting with IL-4–stimulated HUVECs
under flow conditions. Eosinophils rapidly change shape and mi-
grate beneath the monolayer, becoming phase-dark. Videos are
available at http://www.jem.org/cgi/content/full/194/12/1699/
F2/DC1.
 
Results
 
IL-4-, but Not TNF-stimulated Endothelial Cells Support
Rapid Eosinophil Transmigration.
 
HUVECs were stimu-
lated with IL-4 or TNF, the flow chamber was assembled,
and freshly isolated human eosinophils were perfused
through the chamber at a wall shear stress of 2 dyn/cm
 
2
 
.
The inlet line was switched to buffer at 4 min to prevent
the binding of additional eosinophils. After 6 min eosino-
phil transmigration was assessed by quantifying the percent-
age of phase dark, transmigrated cells. We found that both
IL-4 and TNF supported equivalent levels of eosinophil ac-
cumulation (Fig. 1 A); however, only IL-4–stimulated
HUVECs supported eosinophil transmigration (Fig. 1, B–D).
The rapid transmigration of eosinophils in our system
was a surprising finding, as only primed eosinophils have
previously been reported to transmigrate across IL-4–stim-
ulated HUVECs (20); however, these previous studies
were performed under static conditions using transwell 
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plates. Shear stress has recently been shown to be critical
for lymphocyte transmigration across cytokine-stimulated
HUVECs (28); thus, we next examined the role of shear
stress in eosinophil transmigration.
 
Eosinophil Transmigration on IL-4–stimulated HUVECs Is
Shear Dependent.
 
To assess the role of shear stress in eo-
sinophil transmigration, eosinophils were drawn into the
flow chamber and the inlet line was closed to allow the
eosinophils to settle onto the monolayer in the absence of
shear. The percentage of transmigrated cells was measured
every 2 min for 20 min. Few eosinophils transmigrated un-
der the monolayer under these conditions (Fig. 2 A), al-
though the cells were clearly being activated as demon-
strated by increased motility on the surface of the
endothelial cells (Fig. 2 B, and online supplemental videos).
In addition, under static conditions eosinophils were fre-
quently observed to put out processes in an attempt to
transmigrate, but, after failing to transmigrate, they re-
tracted these processes and moved to another site on the
monolayer (online supplemental videos). These partially
transmigrated cells were occasionally observed on the
monolayer and account for some of the cells quantified as
transmigrated (Fig. 2 A). These interactions were recorded
and time-lapse video microscopy clearly showed that under
static conditions eosinophils move on the surface of the en-
dothelium but generally do not migrate beneath the surface
(Fig. 2 B, and online supplemental videos), whereas under
flow conditions, a majority of eosinophils migrate com-
pletely beneath the monolayer (Fig. 2, and online supple-
mental videos). IL-4 stimulation does lead to some endo-
thelial cell retraction; however, without shear stress,
eosinophils do not migrate under the monolayer even at
sites of exposed matrix. These data show that eosinophil
transmigration is shear dependent.
 
Endothelial Cell Activation in Shear-dependent Eosinophil
Transmigration.
 
Shear stress alone has been shown to acti-
vate extracellular signal–regulated kinase (ERK)1/2 mito-
gen-activated protein (MAP) kinases within minutes in
HUVECs (29). To determine if MAP kinase activation in
endothelial cells was associated with shear-dependent trans-
migration, we pretreated endothelial cells with PD 98059,
an inhibitor of the upstream kinase, MEK1. We found that
PD 98059 significantly attenuated shear-dependent eosino-
phil transmigration (Fig. 3 A). The incubation time and
Figure 1. Eosinophils transmigrate across IL-4-stimulated HUVECs. Tightly confluent monolayers of HUVECs were stimulated for 24 h with M199/A
alone (Control) or M199/A containing 20 ng/ml IL-4 (IL-4). Alternatively, cells were stimulated for 6 h with M199/A containing 20 ng/ml TNF (TNF).
After the incubation, the flow chamber was assembled and isolated eosinophils (5   105/ml) were perfused over the HUVECs for 4 min at a wall shear
stress of 2 dyn/cm2. (A) Accumulation and (B) transmigration were quantified as described in Materials and Methods. Data are mean   SEM of between
3 and 15 experiments. *P   0.001. Representative images of interactions between eosinophils and (C) TNF-stimulated HUVECs (TNF) or eosinophils
and (D) IL-4-stimulated HUVECs (IL-4) were digitally captured at 400  magnification. Eosinophils bound to TNF-stimulated HUVECs remained
phase-bright, whereas eosinophils bound to IL-4–stimulated HUVECs changed shape and transmigrated, becoming phase-dark. 
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concentration of PD 98059 used on HUVECs completely
blocked phosphorylation of ERK1/2 in response to hista-
mine (data not shown). These data suggest that activation
of ERK 1/2 MAP kinases may promote shear-dependent
eosinophil transmigration; however, other mechanisms are
clearly required to induce maximal transmigration.
We next determined if shear stress alone was sufficient
to induce eosinophil transmigration. IL-4–stimulated HU-
VECs were preexposed to shear conditions for 5 min be-
fore perfusion of eosinophils. Transmigration was then ex-
amined in the absence of shear stress. We found that
preexposure of HUVECs to shear stress had no effect on
eosinophil transmigration (Fig. 3 B). We also examined
the role of endothelial cell permeability in shear-depen-
dent transmigration. Histamine acts through a G protein–
coupled receptor to increase tyrosine phosphorylation of
adherens junction proteins and induce cellular permeabil-
ity (30). We pretreated IL-4–stimulated endothelial cells
with histamine to determine if changes in endothelial cell
permeability would alter eosinophil transmigration under
static or shear conditions. We found that pretreating endo-
thelial cells with histamine did not affect the magnitude or
kinetics of the shear-dependent eosinophil transmigration
(Fig. 3 C). Histamine also had no effect on static transmi-
gration at early time points (Fig. 3 C), but did modestly
enhance transmigration at later time points. Despite the
negative effects in this assay, we found that histamine
treatment of endothelial cells did lead to activation as mea-
sured by prostaglandin synthesis (data not shown). Fur-
thermore, histamine treatment of endothelial cells did not
affect shear-dependent transmigration of lymphocytes in a
similar system (28). Thus changes in permeability are not
Figure 2. Eosinophil transmigration across IL-4–stimulated HUVECs is shear dependent. HUVECs were stimulated with M199/A containing 20 ng/
ml IL-4 for 24 h. Eosinophils (5   105/ml) were allowed to interact with IL-4–stimulated HUVECs under static (0 dyn/cm2) or flow (2 dyn/cm2) con-
ditions in the flow chamber. (A) Transmigration was measured every 2 min for 20 min as described in Materials and Methods. Data are mean   SEM of
at least four experiments. *P   0.05. (B) Digitally captured images are presented at 1-min intervals to illustrate the interactions between eosinophils (black
arrow) and IL-4–stimulated HUVECs under static or shear conditions. Data are representative of at least four experiments. 
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sufficient to induce eosinophil transmigration in the ab-
sence of shear stress.
 
Eosinophil Activation through CCR3 Is Required for Shear-
dependent Transendothelial Migration.
 
The rapid shape
change and transmigration of eosinophils on IL-4–stimu-
lated HUVECs clearly demonstrated that these eosinophils
were being activated. Furthermore, we previously showed
that greater than 95% of eosinophils bound to IL-4–stimu-
 
lated HUVECs are firmly attached but that blocking both
 
 
 
4- and 
 
 
 
2-integrins could decrease eosinophil firm adhe-
sion and increase the percentage of rolling cells (7). In this
study we found that blocking both 
 
 
 
4- and 
 
 
 
2-integrins
could also block most eosinophils transmigration (Fig. 4).
This was expected, as few cells were firmly adherent and
firm adhesion is a prerequisite for transmigration. To ad-
dress the mechanisms by which eosinophils were being ac-
tivated, we used pertussis toxin to prevent activation by
chemoattractants acting via G
 
 
 
i
 
-coupled receptors. We
found that pertussis toxin blocked 
 
 
 
65% of eosinophil
transmigration indicating that activation was primarily per-
tussis toxin-sensitive (Fig. 4). CCR3 is the major chemo-
kine receptor on eosinophils and CCR3 mediates its effects
via G
 
 
 
i
 
-coupled receptors, thus we next examined the abil-
ity of an anti-CCR3 antibody to affect eosinophil transmi-
gration. Anti-CCR3 mAb blocked eosinophil transmigra-
tion to the same extent as pertussis toxin (Fig. 4). Neither
pertussis toxin nor anti-CCR 3 mAb prevented the firm
adhesion of eosinophils to IL-4–stimulated HUVECs (data
not shown). This was not unexpected since we have previ-
ously shown that interactions with high concentrations of
VCAM-1 alone can mediate both rolling and firm adhesion
of eosinophils through interactions with 
 
 
 
4-integrins (7).
These data suggest that a majority of eosinophil transmigra-
tion across IL-4–stimulated HUVECs is CCR3-dependent,
but CCR3-independent pathways also participate in eo-
sinophil firm adhesion and transendothelial migration.
 
IL-4–stimulated HUVECs Synthesize mRNA and Protein
for Eotaxin-3.
 
Many CC chemokines act at CCR3 (23).
We used RT-PCR, and in some cases ELISA, to screen
IL-4–stimulated HUVECs for the expression of mRNA
and protein for several of these CCR3-specific chemo-
kines. IL-4–stimulated HUVECs did not express mRNA
or protein for eotaxin, RANTES, or MCP-3 (Fig. 5 A, and
Figure 3. Role of ERK1/2 MAP kinase and endothelial cell permeabil-
ity in shear-dependent eosinophil transmigration. HUVECs were stimu-
lated with M199/A containing 20 ng/ml IL-4 for 24 h. (A) HUVECs
were pretreated with 20  M PD 98059 or an equivalent amount of
DMSO for 30 min before the assembly of the flow chamber. Transmigra-
tion was assessed as described in Fig. 1. (B) The flow chamber was assem-
bled and buffer was perfused across the surface at 2 dyn/cm2 for 5 min.
Eosinophils were then drawn into the chamber, the flow was stopped,
and transmigration was determined every 2 min for 20 min as described
in Fig. 2. (C) IL-4–stimulated HUVECs were treated with 10  M hista-
mine for 5 min before the assembly of the flow chamber. Eosinophils
were allowed to interact with IL-4–stimulated HUVECs under static
(0 dyn/cm2) or flow (2 dyn/cm2) conditions in the flow chamber and
transmigration was assessed as described in Fig. 2. Data are mean   SEM
of at least three experiments. *P   0.05.
Figure 4. Eosinophil transmigration across IL-4–stimulated HUVECs
is pertussis toxin sensitive and CCR3 dependent. HUVECs were stimu-
lated with IL-4 as described in Fig. 1. Eosinophils were pretreated with
250 ng/ml pertussis toxin for 1 h (PTX). Alternatively, eosinophils were
pretreated for 10 min with the following antibodies: 5  g/ml anti- 4-
integrin mAb, 5  g/ml anti- 2-integrin mAb, both anti- 4-integrin
mAb and anti- 2-integrin mAb, or 10  g/ml anti-CCR3 mAb (CCR3).
The flow chamber was assembled and eosinophil transmigration was as-
sessed as described in Fig. 1. Data are mean   SEM of at least three ex-
periments. *P   0.001; ns, not significant. 
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data not shown). In contrast, we did observe mRNA ex-
pression for both MCP-4 and eotaxin-3. MCP-4 showed
basal mRNA expression in control endothelial cells that
was slightly enhanced after stimulation with IL-4 (Fig. 5
A); however, we were unable to detect MCP-4 protein by
Western blotting (data not shown). mRNA for eotaxin-3
was not detected in control HUVECs but was clearly ex-
pressed by IL-4–stimulated HUVECs (Fig. 5 A). Eotaxin-3
is a recently described chemokine that acts at CCR3 (25,
31). Western blotting showed that eotaxin-3 protein was
expressed in IL-4–stimulated HUVECs (Fig. 5 B). The an-
tibody we used had been tested for cross-reactivity with the
eotaxin family, and the data in Fig. 5 B confirmed that
there was no binding to recombinant MCP-4, the closest
known homologue to eotaxin-3 (Fig. 5 B).
 
Eotaxin-3 Is Both Secreted by IL-4–stimulated HUVECs
and Associated with the Surface of IL-4–stimulated HU-
VECs.
 
Newly synthesized chemokines are released into
the medium; however, chemokines can also remain cell-
associated through interactions with proteoglycans on the
cell surface (32, 33). We developed a sandwich ELISA to
quantify eotaxin-3 secretion by IL-4–stimulated HUVECs
and used a cell surface ELISA to evaluate the association of
eotaxin-3 with the surface of HUVEC. Eotaxin-3 was not
detected in the conditioned supernatant from control HU-
VECs, but considerable amounts of eotaxin-3 were de-
tected in supernatants from IL-4–stimulated HUVECs (Fig.
6 A). The amount of eotaxin-3 detected in the conditioned
supernatants from IL-4–stimulated HUVECs was 7.97 
 
 
 
1.79 ng/ml. Using a cell surface ELISA, eotaxin-3 was also
found associated with the cell surface of IL-4–stimulated
HUVECs (Fig. 6 B).
 
Cell-associated Eotaxin-3 Participates in Eosinophil Transmi-
gration on IL-4–stimulated HUVECs.
 
Our eotaxin-3 anti-
body blocks functional activity of this chemokine, thus we
used this tool to determine if eotaxin-3 was responsible for
the CCR3-dependent eosinophil activation and subse-
quent transmigration on IL-4–stimulated HUVECs. As our
studies are performed under flow conditions, eotaxin-3 re-
leased into the supernatant is unlikely to participate in eo-
sinophil activation. We therefore treated HUVECs with
anti–eotaxin-3 antibody for 10 min before assembly of the
flow chamber. Pretreatment of IL-4–stimulated HUVECs
with an anti–eotaxin-3 antibody blocked eosinophil trans-
migration (Fig. 7). This was specific for eotaxin-3, as nei-
ther an isotype control antibody nor antibodies against eo-
taxin or RANTES had any effect on transmigration (data
Figure 5. IL-4–stimulated HUVECs
express eotaxin-3 mRNA and protein.
HUVECs were stimulated for 24 h
with M199/A alone or M199/A con-
taining 20 ng/ml IL-4. (A) RNA was
isolated from HUVECs using the TRI-
zol method and cDNA was generated
using a First Strand synthesis kit. PCR
was performed on cDNA using prim-
ers specific for CCR3 chemokines.
Products were separated on agarose
gels and visualized using ethidium bro-
mide.  -actin served as a positive con-
trol. (B) HUVECs were lysed in a
buffer containing Triton X-100 and
lysates were separated by SDS-PAGE.
Proteins were transferred to PVDF and eotaxin-3 protein was detected
using an eotaxin-3-specific antibody. Figures are representative of at least
three experiments.
Figure 6. Eotaxin-3 protein is secreted by and associated with the sur-
face of IL-4–stimulated HUVECs. HUVECs were stimulated for 24 h
with M199/A alone or M199/A containing 20 ng/ml IL-4. (A) Superna-
tants were collected, and soluble eotaxin-3 was measured using a sand-
wich ELISA as described in Materials and Methods. (B) Surface-associated
eotaxin-3 was detected using a cell-surface ELISA with nonimmune goat
antibody (NI IgG) and anti-eotaxin-3 antibody as described in Materials
and Methods. Data are mean   SEM of at least five experiments. *P  
0.05; ns, not significant.
Figure 7. Surface-associated eotaxin-3 is responsible for the CCR3-
dependent transmigration of eosinophils across IL-4–stimulated HU-
VECs. HUVECs were stimulated with IL-4 as described in Fig. 1. Freshly
isolated eosinophils (5   105/ml) were preincubated with 10  g/ml of
antibody against CCR3. In some experiments, HUVECs were preincu-
bated for 10 min with 20  g/ml of antibody against eotaxin-3 and then
10  g/ml of eotaxin-3 was maintained in the perfusate. Isotype-matched
control antibodies were used in all cases. The flow chamber was assem-
bled and eosinophils were perfused over the HUVECs as described in Fig.
1. Transmigration was measured as described in Materials and Methods.
Data are mean   SEM of at least three experiments. *P   0.001 com-
pared with control and † not significant compared with Eotaxin-3 or
CCR3 alone.1706 Shear-dependent Eosinophil Transmigration
not shown). Both eotaxin-3 and CCR3 antibodies inhib-
ited transmigration to the same extent (Fig. 7), and the ef-
fect of the antibodies together was not statistically different
from the effect of either antibody alone (Fig. 7). This indi-
cates that eotaxin-3 is responsible for all of the CCR3-
dependent eosinophil activation and transmigration. In ad-
dition, cell-associated eotaxin-3 was critical in eosinophil
transmigration, as the addition of eotaxin-3 antibody to the
perfusate alone without pretreating the HUVECs resulted
in only a small degree of inhibition (data not shown). Fur-
thermore, preexposure of HUVECs to shear for 5 min to
remove any soluble eotaxin-3 before perfusion of eosino-
phils had no effect on shear-dependent transmigration (data
not shown).
Discussion
In this study, we present the first in vitro examination of
eosinophil transmigration under shear conditions. We ob-
served that eosinophils rapidly transmigrated across IL-4–
stimulated HUVECs under flow conditions. After only 6
min of interaction with the endothelial cell monolayer,
 50% of eosinophils had transmigrated. This number in-
creased even further, with over 80% of all recruited cells
transmigrating in less than 20 min. This rapid transmigra-
tion under flow conditions in vitro is consistent with in
vivo findings (34), but differs significantly from previous
reports of eosinophil transmigration measured using static
assays. Using these systems, Moser et al. showed that eo-
sinophils will selectively bind to IL-4–stimulated HUVECs
(35), but will not transmigrate unless they have been
primed (20, 35). Priming is also required for eosinophil
transmigration across IL-1 –stimulated HUVECs (36).
Priming can occur in vivo, as in the case of cells isolated
from allergic asthmatics, or in vitro by treatment with IL-5,
or GM-CSF (20, 36). Even using eosinophils from allergic
asthmatics, transmigration still requires hours to occur and
only 35–40% of the cells transmigrate (20, 36). Consistent
with these reports, we also found that few cells completely
transmigrated in the absence of shear. These data suggest
that shear stress strongly promotes eosinophil transmigra-
tion across IL-4–stimulated HUVECs.
The transmigration of leukocytes including neutrophils,
monocytes, and lymphocytes has been examined under
flow conditions (5, 16, 17, 37). Only recently, however,
have groups such as Cinamon et al. (28) and Kitayama et
al. (17) systematically examined the role of shear stress in
facilitating leukocyte transmigration. Cinamon et al.
showed that shear stress is absolutely required for T lym-
phocyte transmigration across cytokine-stimulated HU-
VECs, as no transmigration occurs under static conditions
(28). In contrast, Kitayama et al. showed that neutrophil
transmigration across cytokine-stimulated HUVECs is ac-
celerated by shear stress, but is not dependent on shear
stress, as transmigration eventually plateaus at the same
level under either static or shear conditions (17). Our study
shows that eosinophils more closely resemble lymphocytes
than neutrophils in that eosinophils require shear stress to
reach maximal levels of transmigration. Unlike lympho-
cytes, however, eosinophils showed a basal level of trans-
migration under static conditions. These data indicate that
the effect of shear stress on transmigration is dependent
upon the subclass of leukocyte examined.
The specific mechanisms that govern shear-dependent
eosinophil transmigration may be related to signaling
events within the endothelial cells. Endothelial cell signal-
ing events induced by fluid shear stress include increases in
intracellular calcium (38), activation of Src-family kinases
and focal adhesion kinase (39, 40), and activation of MAP
kinases (40, 41). Activation of these kinases occurs within
minutes and has been shown to result in dynamic changes
in the actin cytoskeleton (42). Thus fluid shear stress rapidly
activates multiple signaling cascades in endothelial cells.
However, shear stress alone is not capable of promoting
eosinophil transmigration. Preexposure of the endothelium
to shear stress did not increase eosinophil transmigration
under static conditions (Fig. 3), consistent with studies of
shear-dependent transmigration of neutrophils and lym-
phocytes (17, 43). This may reflect an inability of shear
stresses of 2 dyne/cm2 alone to induce signaling in the en-
dothelium. These relatively low shear stresses may instead
serve to prime endothelial cells for activation of signaling
pathways, and a second stimulus, such as leukocyte adhe-
sion, may be required for a full response.
Neutrophil adhesion to endothelial cells results in cal-
cium mobilization (44), myosin light chain kinase phos-
phorylation (45, 46), and MAP kinase activation (47, 48) in
endothelial cells. Many of these events are critical for sub-
sequent neutrophil transmigration (46, 49). Unlike neutro-
phils, unprimed eosinophils will not transmigrate across
stimulated HUVECs under static conditions. This may re-
flect an inability for unprimed eosinophils to elicit these re-
sponses in endothelial cells. Eosinophil adhesion combined
with shear stress could synergistically activate signaling cas-
cades within endothelial cells, thereby inducing changes in
the cytoskeleton and cellular junctions that promote trans-
migration. Our data suggests that endothelial ERK1/2 is
being activated after eosinophil adhesion under shear con-
ditions, as an inhibitor of ERK1/2 activation blocked
 35% of eosinophil transmigration. We are currently in-
vestigating both the specific targets of ERK1/2 as well as
the upstream activators of this MAP kinase.
Eosinophils accumulated on both TNF- and IL-4–stim-
ulated HUVECs under shear conditions, but transmigra-
tion was selective for IL-4–stimulated HUVECs (Fig. 1).
This suggests that although fluid shear stress is required for
eosinophil transmigration, shear stress alone is not suffi-
cient to induce transmigration. Both in vivo and in vitro
investigations into the mechanisms by which IL-4 supports
increased eosinophil recruitment have focused primarily
on adhesion molecule expression. In this study we instead
focused on the role of chemokines in eosinophil transmi-
gration across activated endothelial cells, however, unlike
other studies, we did not use exogenously added chemo-
kines to promote transmigration (43). We found that eo-1707 Cuvelier and Patel
sinophil transmigration was, in part, pertussis toxin-sensi-
tive and inhibited by an antibody directed against CCR3.
Endogenously synthesized eotaxin-3 was responsible for the
CCR3-dependent eosinophil activation and transmigra-
tion observed in this system. Eotaxin-3 is a newly de-
scribed CC chemokine that was cloned from IL-4–stimu-
lated HUVECs (25, 31). Eotaxin-3 mRNA is upregulated
in dermal fibroblasts after stimulation with IL-4 and in the
airways after antigen challenge (50, 51); however, this is
the first example of a role for endogenous eotaxin-3 in
eosinophil recruitment.
Endothelial cell–associated eotaxin-3, and not secreted
eotaxin-3, was involved in eosinophil transmigration. Sev-
eral chemokines are cell-associated due to interactions with
proteoglycans expressed by endothelial cells (33, 52–54). It
has been proposed that surface association of endothelial
chemokines leads to the establishment of haptotactic gradi-
ents at sites of inflammation. These gradients could be
maintained even in the presence of shear, where soluble
gradients would be rapidly dispersed. Although we did not
examine the distribution of eotaxin-3 on the surface of
HUVECs, increased expression near the cellular junctions
and deposition within the subendothelial cell matrix may
account for the ability of this chemokine to promote trans-
migration. Alternatively, a haptotactic gradient may not be
required for eotaxin-3 to stimulate transmigration in the
presence of shear. Soluble monocyte chemoattractant pro-
tein-1 (MCP-1) has been shown to promote monocyte
transmigration across TNF-stimulated HUVECs under
flow conditions, suggesting that immobilized chemokine
gradients are not required (37). Additionally, lymphocytes
transmigrate from high to low concentration across an im-
mobilized gradient of stromal cell–derived factor-1  (SDF-
1 ) or EBI-1 molecular ligand chemokine (ELC) in the
presence of shear (28). These studies challenge the assump-
tion that chemokine gradients are required for leukocyte
transmigration, and suggest that endothelial cell–derived
chemokines simply serve to initiate transmigration, while
other signals give directionality to the leukocyte migration.
Our laboratory is currently examining both the mecha-
nisms that govern eotaxin-3 cell-association and the local-
ization of eotaxin-3 on HUVECs.
Several groups have begun to focus on the role of che-
mokine and cytokine networks in selective leukocyte re-
cruitment (37, 55, 56). Chemokines associated with endo-
thelial cells promote leukocyte activation, firm adhesion,
and transmigration. These activated cells must now ignore
this chemokine and follow a hierarchy of alternating che-
motactic gradients. By using multiple chemotactic signals,
each of which is active toward a particular leukocyte sub-
class, specific subclasses of leukocytes can be attracted
while others are left behind. Surface-associated eotaxin-3
may serve as the first chemokine in a network of signals
that leads to eosinophil infiltration into sites of allergic in-
flammation. Both groups that cloned and initially charac-
terized eotaxin-3 showed that eotaxin-3 is  10-fold less
active than eotaxin. When these two chemokines are used
at equal concentrations, eotaxin-3 does not completely de-
sensitize eosinophils to subsequent stimulation by eotaxin
(25, 31). Thus, once cells have transmigrated in response to
eotaxin-3, they may still be able to respond in a CCR3-
dependent manner to an eotaxin gradient established in the
tissue. In addition, CCR3-independent mechanisms may
also modulate responsiveness to secondary chemotactic
gradients.
This study demonstrates that shear stress is critical in the
rapid transendothelial migration of eosinophils and suggests
that examining leukocyte transmigration under the flow
conditions found in the vasculature may better recapitulate
the mechanisms of leukocyte trafficking in vivo. Further-
more, we show that a novel eosinophil chemokine, eo-
taxin-3, is both surface associated and critical in supporting
eosinophil transmigration across IL-4–stimulated HUVECs
under flow conditions. Eotaxin-3 may also serve as a selec-
tive signal for eosinophil infiltration into sites of allergic in-
flammation. Future studies will focus on the signaling path-
ways activated during adhesion under shear forces and how
these pathways influence the transmigration process.
We thank Evelyn Lailey and Bao Dang for their excellent technical
assistance, Unit 51 at the Foothills Hospital in Calgary, Alberta for
providing human umbilical cords, Shahina Ali for her constructive
suggestions, and Dr. Paul Kubes for critical reading of this manu-
script.
Susan L. Cuvelier is supported by the National Science and En-
gineering Research Council of Canada and the Alberta Heritage
Foundation for Medical Research, and Kamala D. Patel is sup-
ported by the Alberta Heritage Foundation for Medical Research
and the Canada Research Chairs Program. This study was funded
by a grant from the Canadian Institutes for Health Research.
Submitted: 23 April 2001
Revised: 8 October 2001
Accepted: 23 October 2001
References
1. Frigas, E., S. Motojima, and G.J. Gleich. 1991. The eosino-
philic injury to the mucosa of the airways in the pathogenesis
of bronchial asthma. Eur. Respir. J. (Suppl. 13):123s–135s.
2. Gleich, G.J. 1990. The eosinophil and bronchial asthma: cur-
rent understanding. J. Allergy Clin. Immunol. 85:422–436.
3. Wardlaw, A.J., R. Moqbel, and A.B. Kay. 1995. Eosinophils:
biology and role in disease. Adv. Immunol. 60:151–266.
4. Spertini, O., F.W. Luscinskas, M.A. Gimbrone, Jr., and T.F.
Tedder. 1992. Monocyte attachment to activated human vas-
cular endothelium in vitro is mediated by leukocyte adhesion
molecule-1 (L-selectin) under nonstatic conditions. J. Exp.
Med. 175:1789–1792.
5. Gopalan, P.K., A.R. Burns, S.I. Simon, S. Sparks, L.V.
McIntire, and C.W. Smith. 2000. Preferential sites for sta-
tionary adhesion of neutrophils to cytokine-stimulated HUVEC
under flow conditions. J. Leukoc. Biol. 68:47–57.
6. Abe, Y., C.M. Ballantyne, and C.W. Smith. 1996. Functions
of domain 1 and 4 of vascular cell adhesion molecule-1 in
alpha4 integrin-dependent adhesion under static and flow
conditions are differentially regulated. J. Immunol. 157:5061–
5069.
7. Patel, K.D. 1998. Eosinophil tethering to interleukin-4-acti-1708 Shear-dependent Eosinophil Transmigration
vated endothelial cells requires both P-selectin and vascular
cell adhesion molecule-1. Blood. 92:3904–3911.
8. Woltmann, G., C.A. McNulty, G. Dewson, F.A. Symon,
and A.J. Wardlaw. 2000. Interleukin-13 induces PSGL-1/P-
selectin-dependent adhesion of eosinophils, but not neutro-
phils, to human umbilical vein endothelial cells under flow.
Blood. 95:3146–3152.
9. Brown, M.A., and J. Hural. 1997. Functions of IL-4 and
control of its expression. Crit. Rev. Immunol. 17:1–32.
10. Hickey, M.J., D.N. Granger, and P. Kubes. 1999. Molecular
mechanisms underlying IL-4-induced leukocyte recruitment
in vivo: a critical role for the alpha 4 integrin. J. Immunol.
163:3441–3448.
11. Patel, K.D. 1999. Mechanisms of selective leukocyte recruit-
ment from whole blood on cytokine-activated endothelial
cells under flow conditions. J. Immunol. 162:6209–6216.
12. Springer, T.A. 1995. Traffic signals on endothelium for lym-
phocyte recirculation and leukocyte emigration. Annu. Rev.
Physiol. 57:827–872.
13. Tedder, T.F., D.A. Steeber, A. Chen, and P. Engel. 1995.
The selectins: vascular adhesion molecules. FASEB J. 9:866–
873.
14. Taub, D.D. 1996. Chemokine-leukocyte interactions. The
voodoo that they do so well. Cytokine Growth Factor Rev.
7:355–376.
15. Muller, W.A., and G.J. Randolph. 1999. Migration of leuko-
cytes across endothelium and beyond: molecules involved in
the transmigration and fate of monocytes. J. Leukoc. Biol. 66:
698–704.
16. Allport, J.R., W.A. Muller, and F.W. Luscinskas. 2000.
Monocytes induce reversible focal changes in vascular endo-
thelial cadherin complex during transendothelial migration
under flow. J. Cell Biol. 148:203–216.
17. Kitayama, J., A. Hidemura, H. Saito, and H. Nagawa. 2000.
Shear stress affects migration behavior of polymorphonuclear
cells arrested on endothelium. Cell. Immunol. 203:39–46.
18. Ebisawa, M., B.S. Bochner, S.N. Georas, and R.P. Schlei-
mer. 1992. Eosinophil transendothelial migration induced by
cytokines. I. Role of endothelial and eosinophil adhesion
molecules in IL-1 beta-induced transendothelial migration. J.
Immunol. 149:4021–4028.
19. Ebisawa, M., T. Yamada, C. Bickel, D. Klunk, and R.P.
Schleimer. 1994. Eosinophil transendothelial migration in-
duced by cytokines. III. Effect of the chemokine RANTES.
J. Immunol. 153:2153–2160.
20. Moser, R., J. Fehr, L. Olgiati, and P.L. Bruijnzeel. 1992. Mi-
gration of primed human eosinophils across cytokine-acti-
vated endothelial cell monolayers. Blood. 79:2937–2945.
21. Murdoch, C., and A. Finn. 2000. Chemokine receptors and
their role in inflammation and infectious diseases. Blood. 95:
3032–3043.
22. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human che-
mokines: an update. Annu. Rev. Immunol. 15:675–705.
23. Teran, L.M. 2000. CCL chemokines and asthma. Immunol.
Today. 21:235–242.
24. Heath, H., S. Qin, P. Rao, L. Wu, G. LaRosa, N. Kassam,
P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor
usage by human eosinophils. The importance of CCR3 dem-
onstrated using an antagonistic monoclonal antibody. J. Clin.
Invest. 99:178–84.
25. Shinkai, A., H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa,
A. Saito, T. Takeda, S. Imabeppu, Y. Kato, N. Hanai, et al.
1999. A novel human CC chemokine, eotaxin-3, which is
expressed in IL-4- stimulated vascular endothelial cells, ex-
hibits potent activity toward eosinophils. J. Immunol. 163:
1602–1610.
26. Zimmerman, G.A., T.M. McIntyre, and S.M. Prescott.
1985. Thrombin stimulates the adherence of neutrophils to
human endothelial cells in vitro. J. Clin. Invest. 76:2235–
2246.
27. Ali, S., J. Kaur, and K.D. Patel. 2000. Intercellular cell adhe-
sion molecule-1, vascular cell adhesion molecule- 1, and reg-
ulated on activation normal T cell expressed and secreted are
expressed by human breast carcinoma cells and support eosin-
ophil adhesion and activation. Am. J. Pathol. 157:313–321.
28. Cinamon, G., V. Shinder, and R. Alon. 2001. Shear forces
promote lymphocyte migration across vascular endothelium
bearing apical chemokines. Nat. Immunol. 2:515–522.
29. Ishida, T., T.E. Peterson, N.L. Kovach, and B.C. Berk.
1996. MAP kinase activation by flow in endothelial cells.
Role of beta 1 integrins and tyrosine kinases. Circ. Res. 79:
310–316.
30. Andriopoulou, P., P. Navarro, A. Zanetti, M.G. Lampug-
nani, and E. Dejana. 1999. Histamine induces tyrosine phos-
phorylation of endothelial cell-to-cell adherens junctions. Ar-
terioscler. Thromb. Vasc. Biol. 19:2286–2297.
31. Kitaura, M., N. Suzuki, T. Imai, S. Takagi, R. Suzuki, T.
Nakajima, K. Hirai, H. Nomiyama, and O. Yoshie. 1999.
Molecular cloning of a novel human CC chemokine (Eo-
taxin-3) that is a functional ligand of CC chemokine receptor
3. J. Biol. Chem. 274:27975–27980.
32. Luster, A.D., S.M. Greenberg, and P. Leder. 1995. The IP-
10 chemokine binds to a specific cell surface heparan sulfate
site shared with platelet factor 4 and inhibits endothelial cell
proliferation. J. Exp. Med. 182:219–231.
33. Webb, L.M., M.U. Ehrengruber, I. Clark-Lewis, M. Baggio-
lini, and A. Rot. 1993. Binding to heparan sulfate or heparin
enhances neutrophil responses to interleukin 8. Proc. Natl.
Acad. Sci. USA. 90:7158–7162.
34. Woodman, R.C., B. Johnston, M.J. Hickey, D. Teoh, P.
Reinhardt, B.Y. Poon, and P. Kubes. 1998. The functional
paradox of CD43 in leukocyte recruitment: a study using
CD43-deficient mice. J. Exp. Med. 188:2181–2186.
35. Moser, R., J. Fehr, and P.L. Bruijnzeel. 1992. IL-4 controls
the selective endothelium-driven transmigration of eosino-
phils from allergic individuals. J. Immunol. 149:1432–1438.
36. Ebisawa, M., M.C. Liu, T. Yamada, M. Kato, L.M. Lichten-
stein, B.S. Bochner, and R.P. Schleimer. 1994. Eosinophil
transendothelial migration induced by cytokines. II. Potenti-
ation of eosinophil transendothelial migration by eosinophil-
active cytokines. J. Immunol. 152:4590–4596.
37. Weber, K.S., P. von Hundelshausen, I. Clark-Lewis, P.C.
Weber, and C. Weber. 1999. Differential immobilization and
hierarchical involvement of chemokines in monocyte arrest
and transmigration on inflamed endothelium in shear flow.
Eur. J. Immunol. 29:700–712.
38. Hoyer, J., R. Kohler, and A. Distler. 1998. Mechanosensitive
Ca2  oscillations and STOC activation in endothelial cells.
FASEB J. 12:359–366.
39. Li, S., M. Kim, Y.L. Hu, S. Jalali, D.D. Schlaepfer, T.
Hunter, S. Chien, and J.Y. Shyy. 1997. Fluid shear stress ac-
tivation of focal adhesion kinase. Linking to mitogen-acti-
vated protein kinases. J. Biol. Chem. 272:30455–30462.
40. Okuda, M., M. Takahashi, J. Suero, C.E. Murry, O. Traub,
H. Kawakatsu, and B.C. Berk. 1999. Shear stress stimulation
of p130(cas) tyrosine phosphorylation requires calcium-depen-1709 Cuvelier and Patel
dent c-Src activation. J. Biol. Chem. 274:26803–26809.
41. Takahashi, M., T. Ishida, O. Traub, M.A. Corson, and B.C.
Berk. 1997. Mechanotransduction in endothelial cells: tem-
poral signaling events in response to shear stress. J. Vasc. Res.
34:212–219.
42. Li, S., B.P. Chen, N. Azuma, Y.L. Hu, S.Z. Wu, B.E. Sum-
pio, J.Y. Shyy, and S. Chien. 1999. Distinct roles for the
small GTPases Cdc42 and Rho in endothelial responses to
shear stress. J. Clin. Invest. 103:1141–1150.
43. Cinamon, G., V. Grabovsky, E. Winter, S. Franitza, S. Fei-
gelson, R. Shamri, O. Dwir, and R. Alon. 2001. Novel
chemokine functions in lymphocyte migration through vas-
cular endothelium under shear flow. J. Leukoc. Biol. 69:860–
866.
44. Lorenzon, P., E. Vecile, E. Nardon, E. Ferrero, J.M. Harlan,
F. Tedesco, and A. Dobrina. 1998. Endothelial cell E- and
P-selectin and vascular cell adhesion molecule-1 function as
signaling receptors. J. Cell Biol. 142:1381–1391.
45. Saito, H., Y. Minamiya, M. Kitamura, S. Saito, K. Enomoto,
K. Terada, and J. Ogawa. 1998. Endothelial myosin light
chain kinase regulates neutrophil migration across human
umbilical vein endothelial cell monolayer. J. Immunol. 161:
1533–1540.
46. Garcia, J.G., A.D. Verin, M. Herenyiova, and D. English.
1998. Adherent neutrophils activate endothelial myosin light
chain kinase: role in transendothelial migration. J. Appl. Phys-
iol. 84:1817–1821.
47. Simon, S.I., Y. Hu, D. Vestweber, and C.W. Smith. 2000.
Neutrophil tethering on E-selectin activates beta 2 integrin
binding to ICAM-1 through a mitogen-activated protein ki-
nase signal transduction pathway. J. Immunol. 164:4348–
4358.
48. Hu, Y., J.M. Kiely, B.E. Szente, A. Rosenzweig, and M.A.
Gimbrone, Jr. 2000. E-selectin-dependent signaling via the
mitogen-activated protein kinase pathway in vascular endo-
thelial cells. J. Immunol. 165:2142–2148.
49. Huang, A.J., J.E. Manning, T.M. Bandak, M.C. Ratau, K.R.
Hanser, and S.C. Silverstein. 1993. Endothelial cell cytosolic
free calcium regulates neutrophil migration across monolayers
of endothelial cells. J. Cell Biol. 120:1371–1380.
50. Dulkys, Y., G. Schramm, D. Kimmig, S. Knoss, A. Weyer-
graf, A. Kapp, and J. Elsner. 2001. Detection of mRNA for
eotaxin-2 and eotaxin-3 in human dermal fibroblasts and
their distinct activation profile on human eosinophils. J. In-
vest. Dermatol. 116:498–505.
51. Berkman, N., S. Ohnona, F.K. Chung, and R. Breuer. 2001.
Eotaxin-3 but not eotaxin gene expression is upregulated in
asthmatics 24 hours after allergen challenge. Am. J. Respir.
Cell. Mol. Biol. 24:682–687.
52. Middleton, J., S. Neil, J. Wintle, I. Clark-Lewis, H. Moore,
C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis
and surface presentation of IL-8 by venular endothelial cells.
Cell. 91:385–395.
53. Hoogewerf, A.J., G.S. Kuschert, A.E. Proudfoot, F. Borlat, I.
Clark-Lewis, C.A. Power, and T.N. Wells. 1997. Gly-
cosaminoglycans mediate cell surface oligomerization of che-
mokines. Biochemistry. 36:13570–13578.
54. Hub, E., and A. Rot. 1998. Binding of RANTES, MCP-1,
MCP-3, and MIP-1alpha to cells in human skin. Am. J.
Pathol. 152:749–757.
55. Foster, P.S., A.W. Mould, M. Yang, J. Mackenzie, J. Mattes,
S.P. Hogan, S. Mahalingam, A.N. McKenzie, M.E. Rothen-
berg, I.G. Young, et al. 2001. Elemental signals regulating
eosinophil accumulation in the lung. Immunol. Rev. 179:173–
181.
56. Foxman, E.F., J.J. Campbell, and E.C. Butcher. 1997. Multi-
step navigation and the combinatorial control of leukocyte
chemotaxis. J. Cell Biol. 139:1349–1360.